These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 944395)

  • 1. Migraine attacks. Alleviation by an inhibitor of prostaglandin synthesis and action.
    Vardi Y; Rabey IM; Streifler M; Schwartz A; Lindner HR; Zor U
    Neurology; 1976 May; 26(5):447-50. PubMed ID: 944395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmoplegic migraine: amelioration by Flufenamic acid, a prostaglandin inhibitor.
    Rabey JM; Vardi Y; Van Dyck D; Streifler M
    Ophthalmologica; 1977; 175(3):148-52. PubMed ID: 331178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flufenamic acid in prostaglandin migraine.
    Carasso RL; Peled O; Yehuda S
    Int J Neurosci; 1985 Jul; 27(1-2):67-71. PubMed ID: 4019063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary dysmenorrhea: alleviation by an inhibitor of prostaglandin synthesis and action.
    Schwartz A; Zor U; Lindner HR; Naor S
    Obstet Gynecol; 1974 Nov; 44(5):709-12. PubMed ID: 4213653
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of flufenamic acid in migraine attacks.
    Steardo L; Sorge F; Florio C
    Acta Neurol (Napoli); 1979 Aug; 1(4):271-7. PubMed ID: 532733
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo.
    Al-Waili NS
    Eur J Med Res; 2000 Apr; 5(4):176-82. PubMed ID: 10799353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study.
    Kapadia L; Elder MG
    Lancet; 1978 Feb; 1(8060):348-50. PubMed ID: 75392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Migraine and non-steroidal anti-inflammatory agents].
    Pradalier A; Vincent D
    Pathol Biol (Paris); 1992 Apr; 40(4):397-405. PubMed ID: 1495823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of migraine by an antiprostaglandin].
    Rabey IM; Zor U; Schwartz A; Vardi J
    Harefuah; 1976 Dec; 91(11):387-8. PubMed ID: 1017731
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
    Cutler NR; Jhee SS; Majumdar AK; McLaughlin D; Brucker MJ; Carides AD; Kramer MS; Matzura-Wolfe D; Reines SA; Goldberg MR
    Headache; 1999 Apr; 39(4):264-9. PubMed ID: 15613223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of an isopyrine-phenylbutazone compound in migraine.
    Sacks W
    S Afr Med J; 1980 Sep; 58(11):444-6. PubMed ID: 6996149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial.
    Misra UK; Jose M; Kalita J
    Postgrad Med J; 2004 Dec; 80(950):720-3. PubMed ID: 15579612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks.
    Kinnunen E; Erkinjuntti T; Färkkilä M; Palomäki H; Porras J; Teirmaa H; Freudenthal Y; Andersson P
    Cephalalgia; 1988 Sep; 8(3):175-9. PubMed ID: 3143482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolfenamic acid and migraine--aspects on prostaglandins and leukotrienes.
    Vapaatalo H
    Pharmacol Toxicol; 1994; 75 Suppl 2():76-80. PubMed ID: 7816789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995).
    Kapicioğlu S; Gökce E; Kapicioğlu Z; Ovali E
    Cephalalgia; 1997 Feb; 17(1):27-30. PubMed ID: 9051332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.